Assessment of myocardial structure and function in rheumatoid arthritis patients treated with biologics: tumor necrosis factor inhibitors and anti-interleukin-6 versus conventional disease-modifying drugs
Biologics, irrespective of their specific mechanisms, significantly reduce disease activity, which positively influences LV mass and reduces the incidence of LV hypertrophy. Additionally, biologics do not adversely affect cardiac electrical function.
Authors
- Aleksander Jerzy Owczarek (ORCID: https://orcid.org/0000-0003-1179-6932)
- Przemysław Kotyla (ORCID: https://orcid.org/0000-0001-8376-6527)
- Olga Gumkowska-Sroka (ORCID: https://orcid.org/0000-0001-6211-3762)
- Kacper Kotyla
- Jan Kurdybacha
- Beata Dubiel-Braszczok (ORCID: https://orcid.org/0000-0001-5554-3801)
- Aleksandra Marcol
Institutions
- Medical University of Silesia (PL)
Publication Details
- Journal
- Reumatologia/Rheumatology
- Published
- 2025-11-11
- DOI
- https://doi.org/10.5114/reum/203546
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00